363 related articles for article (PubMed ID: 26242311)
21. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
[TBL] [Abstract][Full Text] [Related]
22. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
23. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
Blumenthal MJ; Schutz C; Barr D; Locketz M; Marshall V; Whitby D; Katz AA; Uldrick T; Meintjes G; Schäfer G
J Infect Dis; 2019 Jul; 220(5):841-851. PubMed ID: 31004430
[TBL] [Abstract][Full Text] [Related]
24. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
25. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma.
Tam HK; Zhang ZF; Jacobson LP; Margolick JB; Chmiel JS; Rinaldo C; Detels R
Int J Cancer; 2002 Apr; 98(6):916-22. PubMed ID: 11948473
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
Ramaswami R; Lurain K; Polizzotto MN; Ekwede I; Waldon K; Steinberg SM; Mangusan R; Widell A; Rupert A; George J; Gonçalves PH; Marshall VA; Whitby D; Wang HW; Pittaluga S; Jaffe ES; Little RF; Uldrick TS; Yarchoan R
Blood Adv; 2021 Mar; 5(6):1660-1670. PubMed ID: 33720337
[TBL] [Abstract][Full Text] [Related]
27. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.
Powles T; Stebbing J; Bazeos A; Hatzimichael E; Mandalia S; Nelson M; Gazzard B; Bower M
Ann Oncol; 2009 Apr; 20(4):775-9. PubMed ID: 19179554
[TBL] [Abstract][Full Text] [Related]
28. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?
Sayer R; Paul J; Tuke PW; Hargreaves S; Noursadeghi M; Tedder RS; Grant P; Edwards SG; Miller RF
Int J STD AIDS; 2011 Oct; 22(10):585-9. PubMed ID: 21998180
[TBL] [Abstract][Full Text] [Related]
29. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).
Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Marshall V; Wang V; Whitby D; Pittaluga S; Jaffe ES; Millo C; Tosato G; Little RF; Steinberg SM; Sereti I; Yarchoan R
Clin Infect Dis; 2016 Mar; 62(6):730-738. PubMed ID: 26658701
[TBL] [Abstract][Full Text] [Related]
30. Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
Rogges E; Pelliccia S; Savio C; Lopez G; Della Starza I; La Verde G; Di Napoli A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612584
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
[TBL] [Abstract][Full Text] [Related]
34. CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
Gopal S; Fedoriw Y; Kaimila B; Montgomery ND; Kasonkanji E; Moses A; Nyasosela R; Mzumara S; Varela C; Chikasema M; Makwakwa V; Itimu S; Tomoka T; Kamiza S; Dhungel BM; Chimzimu F; Kampani C; Krysiak R; Richards KL; Shea TC; Liomba NG
PLoS One; 2016; 11(3):e0150445. PubMed ID: 26934054
[TBL] [Abstract][Full Text] [Related]
35. Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.
Rees CA; Keating EM; Lukolyo H; Danysh HE; Scheurer ME; Mehta PS; Lubega J; Slone JS;
Pediatr Blood Cancer; 2016 Aug; 63(8):1325-31. PubMed ID: 27082516
[TBL] [Abstract][Full Text] [Related]
36. Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.
Burbelo PD; Issa AT; Ching KH; Wyvill KM; Little RF; Iadarola MJ; Kovacs JA; Yarchoan R
J Infect Dis; 2010 Jun; 201(12):1919-22. PubMed ID: 20443737
[TBL] [Abstract][Full Text] [Related]
37. Differences in survival among adults with HIV-associated Kaposi's sarcoma during routine HIV treatment initiation in Zomba district, Malawi: a retrospective cohort analysis.
Singogo E; Keegan TJ; Diggle PJ; van Lettow M; Matengeni A; van Oosterhout JJ; Sodhi S; Joshua M; Taylor BM
Int Health; 2017 Sep; 9(5):281-287. PubMed ID: 28911125
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
[TBL] [Abstract][Full Text] [Related]
39. A Rare Case of the Newly Recognized Kaposi Sarcoma Herpesvirus-Associated Disease.
Li Q; Ali F; Kak V; Santos R
Cureus; 2020 Jun; 12(6):e8784. PubMed ID: 32724735
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes for children and adolescents with Kaposi sarcoma.
Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]